Elizabeth Tuck
Primary Care · Lake City, MINPI 1609361807
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.4% of the total across 135 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 22.4% — the pattern of someone who eats at a lot of different presentations.
Across 135 payments — averaging $18.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$557
- Novo Nordisk$238
- Johnson & Johnson$212
- GSK$148
- Regeneron Healthcare Solutions, Inc.$113
- Sanofi$109
- plus $1K from 22 others
What the payments were for
- Food & beverage$2,32793%
- Education$1647%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 34 | $557 |
| Novo Nordisk | 16 | $238 |
| Johnson & Johnson(2 entities) | 9 | $212 |
| GSK | 9 | $148 |
| Regeneron Healthcare Solutions, Inc. | 2 | $113 |
| Sanofi | 5 | $109 |
| Medtronic | 4 | $101 |
| Astellas Pharma US Inc | 5 | $97 |
| E.r. Squibb & Sons, L.L.C. | 5 | $88 |
| Amgen | 4 | $81 |
| Galderma Laboratories, L.p. | 4 | $80 |
| Boehringer Ingelheim | 4 | $78 |
| Sun Pharmaceutical Industries Inc. | 2 | $75 |
| AstraZeneca | 4 | $70 |
| Lilly USA, LLC | 3 | $56 |
| Organon | 6 | $52 |
| Novartis | 2 | $49 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $46 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| Bayer | 2 | $34 |
| Dexcom, Inc. | 2 | $31 |
| Pfizer | 2 | $29 |
| Exact Sciences | 1 | $22 |
| Esperion Therapeutics, Inc. | 1 | $20 |
| Radius Health, Inc. | 1 | $19 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
| Mylan Specialty L.p. | 1 | $15 |
| Merck | 1 | $13 |
How this compares
$2,490 in reported general payments places this provider in the 85th percentile of 292 primary care providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 63 | $236,740 |
| Betamethasone Dipropionate | 94 | $3,971 |
| Fluorouracil | 53 | $3,890 |
| Tacrolimus | 34 | $3,873 |
| Clobetasol Propionate | 88 | $2,464 |
| Metronidazole | 39 | $2,171 |
| Ketoconazole | 122 | $1,753 |
| Tretinoin | 14 | $1,024 |
| Doxycycline Hyclate | 35 | $550 |
| Triamcinolone Acetonide | 62 | $528 |
| Atorvastatin Calcium | 22 | $291 |
| Hydrocortisone | 37 | $277 |
| Lisinopril | 19 | $205 |
| Sertraline Hcl | 14 | $182 |
| Clindamycin Phosphate | 13 | $168 |
Paid to pharmacies, not to this prescriber.
Other primary care in Lake City
- Donna HamillGrosse Pointe$17K
- Marie Sighe-NzokouLansing$16K
- Alexandria SchwabBay City$10K
- Amy HenryRochester Hills$10K
- Claire GebaraWaterford$9K
- Vanita RobinsonDetroit$9K
- Mary BoudreauMason$9K
- Kimberly FrazierLansing$8K
- Rachel HetznerMadison Heights$8K
- Katherine HouleMarquette$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.